Moreno A - Search Results

1

HER-2/neu status and response to CMF: retrospective study in a series of operable breast cancer treated with primary CMF chemotherapy.

Falo C, Moreno A, Varela M, Lloveras B, Figueras A, Escobedo A. Falo C, et al. Among authors: moreno a. J Cancer Res Clin Oncol. 2007 Jul;133(7):423-9. doi: 10.1007/s00432-006-0176-7. Epub 2007 Jan 24. J Cancer Res Clin Oncol. 2007. PMID: 17245595

2

Pathologic changes related to CMF primary chemotherapy in breast cancer. Pathological evaluation of response predicts clinical outcome.

Moreno A, Escobedo A, Benito E, Serra JM, Gumà A, Riu F. Moreno A, et al. Breast Cancer Res Treat. 2002 Sep;75(2):119-25. doi: 10.1023/a:1019607924403. Breast Cancer Res Treat. 2002. PMID: 12243504 Clinical Trial.

3

Algorithm for the diagnosis of HER-2/neu status in breast-infiltrating carcinomas.

Falo C, Moreno A, Lloveras B, Figueras A, Varela M, Escobedo A. Falo C, et al. Among authors: moreno a. Am J Clin Oncol. 2003 Oct;26(5):465-70. doi: 10.1097/01.coc.0000026834.38957.35. Am J Clin Oncol. 2003. PMID: 14528071

4

Primary chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil in operable breast carcinoma.

Falo C, Moreno A, Benito E, Lloveras B, Varela M, Serra JM, Prieto L, Azpeitia D, Escobedo A. Falo C, et al. Among authors: moreno a. Cancer. 2005 Feb 15;103(4):657-63. doi: 10.1002/cncr.20829. Cancer. 2005. PMID: 15648085 Free article. Clinical Trial.

5

Predictive value of HER-2 and Topoisomerase IIalpha in response to primary doxorubicin in breast cancer.

Arriola E, Moreno A, Varela M, Serra JM, Falo C, Benito E, Escobedo AP. Arriola E, et al. Among authors: moreno a. Eur J Cancer. 2006 Nov;42(17):2954-60. doi: 10.1016/j.ejca.2006.06.013. Epub 2006 Aug 28. Eur J Cancer. 2006. PMID: 16935488

6

Overproduction of VEGF concomitantly expressed with its receptors promotes growth and survival of melanoma cells through MAPK and PI3K signaling.

Graells J, Vinyals A, Figueras A, Llorens A, Moreno A, Marcoval J, Gonzalez FJ, Fabra A. Graells J, et al. Among authors: moreno a. J Invest Dermatol. 2004 Dec;123(6):1151-61. doi: 10.1111/j.0022-202X.2004.23460.x. J Invest Dermatol. 2004. PMID: 15610528 Free article.

7

Cutaneous infiltration by cancer.

Marcoval J, Moreno A, Peyrí J. Marcoval J, et al. Among authors: moreno a. J Am Acad Dermatol. 2007 Oct;57(4):577-80. doi: 10.1016/j.jaad.2007.01.034. Epub 2007 Mar 26. J Am Acad Dermatol. 2007. PMID: 17368634

8

Traumatic panniculitis.

Moreno A, Marcoval J, Peyri J. Moreno A, et al. Dermatol Clin. 2008 Oct;26(4):481-3, vii. doi: 10.1016/j.det.2008.06.004. Dermatol Clin. 2008. PMID: 18793980 Review.

9

Necrobiosis lipoidica.

Peyrí J, Moreno A, Marcoval J. Peyrí J, et al. Among authors: moreno a. Semin Cutan Med Surg. 2007 Jun;26(2):87-9. doi: 10.1016/j.sder.2007.02.004. Semin Cutan Med Surg. 2007. PMID: 17544959 Review.

10

Cholesterol embolism: still an unrecognized entity with a high mortality rate.

Jucgla A, Moreso F, Muniesa C, Moreno A, Vidaller A. Jucgla A, et al. Among authors: moreno a. J Am Acad Dermatol. 2006 Nov;55(5):786-93. doi: 10.1016/j.jaad.2006.05.012. Epub 2006 Jun 27. J Am Acad Dermatol. 2006. PMID: 17052483

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

3,466 results

Search Page